Drug
Magnesium isoglycyrrhizinate clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2013 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Cttq (2) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses magnesium isoglycyrrhizinate is read from its arms, and is right about nine times in ten.
Testing it · 3
- Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis BStatus unknownPhase 4CttqNCT03349008Written as Magnesium Isoglycyrrhizinate
- Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver InjuryCompletedPhase 2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT02734966Written as Magnesium Isoglycyrrhizinate Injection 100mg OD
- Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver InjuryStatus unknownPhase 4CttqNCT01802996Written as Magnesium Isoglycyrrhizinate Injection
Given in every arm · 1 — magnesium isoglycyrrhizinate is usual care beside what is tested
As the comparator · 1 — what is tested is compared with magnesium isoglycyrrhizinate
Codes
What other systems call magnesium isoglycyrrhizinate · ClinicalTrials.gg INT005121
- UNII (FDA) 6ZH2XEE84PMAGNESIUM ISOGLYCYRRHIZINATEOne source FDA
- NCI Thesaurus C105617Magnesium IsoglycyrrhizinateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 6ZH2XEE84P | MAGNESIUM ISOGLYCYRRHIZINATE | One source FDA |
| NCI Thesaurus | C105617 | Magnesium Isoglycyrrhizinate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.